In one paragraphArticle in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Adijat Ozohu JimohDivision of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
Anika ChickenDivision of Medical Virology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0001-6166-6269 Brandon MaustCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.ORCID 0000-0002-3174-9036 Colin FengCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Seth Rakoff-NahoumDivision of Infectious Diseases, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Jo-Ann S PassmoreDivision of Medical Virology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
Brian R KullinDivision of Medical Virology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0001-5460-1977 Simona KrabergerThe Biodesign Center for Fundamental and Applied Microbiomics, Center for Evolution and Medicine and School of Life Sciences, Arizona State University, Tempe, AZ 85281, USA.ORCID 0000-0002-7037-9242 Fatima Aysha HussainDepartment of Biology, Tufts University, Medford, MA 02155, USA.
Heather B JaspanDivision of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
Arvind VarsaniThe Biodesign Center for Fundamental and Applied Microbiomics, Center for Evolution and Medicine and School of Life Sciences, Arizona State University, Tempe, AZ 85281, USA.ORCID 0000-0003-4111-2415 Anna-Ursula HappelDivision of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.ORCID 0000-0003-3658-8638 Funding
European & Developing Countries Clinical Trials Partnership TMA2020CDF-3192-VaViBaGates Foundation INV-048980NIH HHS 1R01HD083040-05NIH HHS 1R01HD106821-03Poliomyelitis Research Foundation 22/109
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Genetic VariationGenome, ViralLactobacillus crispatusProphagesVaginaCopperDNA, ViralFemaleGenomicsHumansPhylogenySouth AfricaSouthern African PeopleTenofovirVirus ActivationCopperDNA, ViralTenofovirbacteriophage genomicsLactobacillus crispatusprophage inductionvaginal microbiota
Identifiers
PMID42198722
PMCPMC13211564
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390